HIV PrEP counseling study for Ontario providers and patients
Part of Infections, Mental health clinical trials.
This study tests whether a counseling program helps healthcare providers better support patients who could benefit from PrEP (medicine that prevents HIV). It looks at how well providers identify and discuss PrEP with patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthcare provider (nurse, NP, counselor, or physician) working in a sexual health clinic, public health clinic, or primary care in Ontario.
- You have a valid Ontario license to practice (including as a resident).
- You expect to see at least 5 patients who could benefit from PrEP in the next 3 months.
- You plan to stay at your current job for the study period.
- If you are a patient: You are 19+, identify as a man or gender different from cisgender woman, and haven't used PrEP in the last 3 months.
- You have had condomless anal sex with a man in the past 6 months and meet extra criteria (e.g., recent STI, PEP use, or partner with HIV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a counseling program to help women decide whether to use PrEP (a daily pill that prevents HIV). It aims to make PrEP choices easier and more informed in sexual and reproductive health clinics.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This trial tests ways to help primary care providers and their patients start using PrEP, a daily pill that prevents HIV. It may be right for you if you are interested in HIV prevention.
This study helps make HIV PrEP (a daily pill to prevent HIV) more available through your regular general practitioner, instead of only at specialized clinics. You may qualify if you are at risk for HIV and want to start or restart PrEP.
This study tests a new approach to help men at risk for HIV stay healthy by providing access to PrEP through a mobile app. The goal is to see if the program helps men start and stay on PrEP compared to standard care.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
Hear when a new Pre-Exposure Prophylaxis (PrEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.